Jiangsu Hengrui Medicine
38 Huanghe Rd Eco & Tech Dev Park,
Lianyungang, 222000,
China
Lianyungang, 222000,
China
86 518 8122 0983
Life Sciences
Jiangsu Hengrui Medicine Technographics
Jiangsu Hengrui Medicine Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Jiangsu Hengrui Medicine and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 24491 Jiangsu Hengrui Medicine employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Jiangsu Hengrui Medicine has purchased the following applications: Microsoft 365 for Collaboration in 2021, TeamViewer for Remote Monitoring and Management in 2022, YUEMIA Master Data Management for Master Data Management in 2019 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Jiangsu Hengrui Medicine is running and its propensity to invest more and deepen its relationship with Microsoft , Salesforce , TeamViewer or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Jiangsu Hengrui Medicine revenues, which have grown to $3.76 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Jiangsu Hengrui Medicine intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Jiangsu Hengrui Medicine Tech Stack and Enterprise Applications
Jiangsu Hengrui Medicine Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2021 | 2021 |
In 2021 Jiangsu Hengrui Medicine implemented Microsoft 365 in a deployment that is referenced on the company website, positioning Microsoft 365 within the Collaboration category. The public signal indicates a corporate Microsoft 365 tenancy or licensing footprint tied to enterprise collaboration and content hosting for the organization.
The implementation narrative aligns with core Microsoft 365 Collaboration capabilities, including cloud email and calendaring, real time team collaboration, intranet and document management, and desktop productivity applications, with the full application name Microsoft 365 used in public assets. Configuration patterns typical to this category would include tenant level content governance, document lifecycle controls, and user workspace provisioning to support research collaboration and corporate communications.
Operational coverage is indicated at the corporate level in China, suggesting the Microsoft 365 implementation supports central business functions such as corporate communications, knowledge management, and cross functional collaboration. Governance for the deployment is expected to follow standard Microsoft 365 models for centralized tenant administration and role based access control, consistent with Collaboration category best practices.
|
|
|
|
|
Collaboration | Collaboration |
|
2022 | 2022 |
|
Jiangsu Hengrui Medicine ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| TeamViewer | Legacy | TeamViewer | Remote Monitoring and Management | ITSM | n/a | 2022 | 2022 |
In 2022 Jiangsu Hengrui Medicine implemented TeamViewer as a web facing remote support capability on its corporate website. TeamViewer is deployed as the application in the Remote Monitoring and Management category to enable web initiated remote sessions for support and troubleshooting. The public facing placement establishes a direct channel for customers and internal users to request remote assistance from IT or service teams.
The deployment leverages TeamViewer core capabilities typical of remote monitoring and management, including remote access and control, screen sharing, session initiation from a browser, in session chat, and file transfer to support interactive troubleshooting. Configuration focuses on web widget integration and session management workflows, with browser based handoff to desktop clients for escalated sessions. The implementation emphasizes session authorization and control features that are standard for Remote Monitoring and Management tools.
Operational coverage is centered on the company website in China, positioning TeamViewer as the primary web initiated remote assistance tool for external support and internal IT operations. Governance points implied by the architecture include web widget configuration, session logging, and operator access controls to manage remote sessions. The narrative reflects a web integrated TeamViewer deployment providing remote support capabilities consistent with the Remote Monitoring and Management category.
|
Jiangsu Hengrui Medicine PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| YUEMIA | Legacy | YUEMIA Master Data Management | Master Data Management | PaaS | n/a | 2019 | 2019 |
In 2019, Jiangsu Hengrui Medicine implemented YUEMIA Master Data Management to centralize physician and customer master records and support marketing, CRM, and academic promotion activities in China. The deployment positioned YUEMIA Master Data Management as the authoritative source for contact, specialty, and engagement attributes used by commercial and medical affairs teams.
The implementation leveraged standard Master Data Management capabilities including identity resolution and record linkage, data cleansing and normalization, canonical profile creation, and stewardship workflows for ongoing data quality management. YUEMIA Master Data Management was configured to maintain persistent master records and attribute sets used for segmentation, audience enrichment, and campaign targeting in support of marketing and academic promotion programs.
Operational integration focused on the digital marketing platform provided by YUEMIA and on downstream marketing and CRM consumption, enabling managed exports and synchronized master data for campaign orchestration and academic outreach. The scope of the rollout emphasized commercial and medical affairs functions within China, with role based access and domain stewardship practices implied by the MDM configuration.
Governance changes centered on centralized data stewardship and standardized master record models to enforce consistent physician and customer definitions across marketing and CRM processes. Regional client benefits reported by the vendor include streamlined data driven promotion and lower marketing operating costs.
|
IT Decision Makers and Key Stakeholders at Jiangsu Hengrui Medicine
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Jiangsu Hengrui Medicine Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Jiangsu Hengrui Medicine IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Jiangsu Hengrui Medicine digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Jiangsu Hengrui Medicine Technographics
Jiangsu Hengrui Medicine is a Life Sciences organization based in China,
with around 24491 employees and annual revenues of $3.76 billion.
Jiangsu Hengrui Medicine operates a diverse technology stack with applications such as
Microsoft 365, TeamViewer and YUEMIA Master Data Management,
covering areas like Collaboration, Remote Monitoring and Management and Master Data Management.
Jiangsu Hengrui Medicine has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Microsoft, TeamViewer and YUEMIA.
Jiangsu Hengrui Medicine recently adopted applications including
Slack Connect in 2022, TeamViewer in 2022 and Microsoft 365 in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Jiangsu Hengrui Medicine’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Jiangsu Hengrui Medicine’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Jiangsu Hengrui Medicine technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.